COMMUNIQUÉS West-GlobeNewswire

-
Larimar Therapeutics Reports Second Quarter 2025 Financial Results
14/08/2025 -
Werewolf Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
14/08/2025 -
Balt USA Responds to Patent Infringement Lawsuit Filed by Route 92 Medical
14/08/2025 -
Athira Pharma Presents ATH-1105 Phase 1 Trial Results at ALS Nexus 2025
14/08/2025 -
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
14/08/2025 -
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
14/08/2025 -
Prelude Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
14/08/2025 -
atai Life Sciences Reports Second Quarter 2025 Financial Results and Recent Corporate Updates
14/08/2025 -
Shattuck Labs Reports Second Quarter 2025 Financial Results and Recent Business Highlights
14/08/2025 -
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock
14/08/2025 -
Fennec Pharmaceuticals Reports Second Quarter 2025 Financial Results And Provides Business Update
14/08/2025 -
Zelluna ASA: Invitation to Second Quarter 2025 results webcast presentation
14/08/2025 -
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual Film
14/08/2025 -
À l’occasion de la Journée mondiale du don d’organes, le KFSHRC annonce la réalisation de 10 greffes de reins croisées en 48 heures
14/08/2025 -
Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic
14/08/2025 -
Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease
14/08/2025 -
Communiqué de presse : Le rilzabrutinib de Sanofi obtient la désignation de médicament orphelin dans l’UE pour la maladie liée aux IgG4
14/08/2025 -
Kuros Biosciences Reports First Half of 2025 Results
14/08/2025 -
Zealand Pharma Announces Financial Results for the First Half of 2025
14/08/2025
Pages